ArticleThe Journal of dermatology2025

Long-term real-world effectiveness of deucravacitinib in psoriasis: A 52-week prospective study stratified by prior apremilast or biologic therapy.

Teppei Hagino et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.